Five notes:
1. Fourth quarter sales were $657.3 million. For the full year 2024, net sales were $2.5 billion.
2. Fourth quarter sales in the U.S. grew 6.3% year over year. The growth was driven by Globus’ merger with NuVasive and increased spine products and enabling technology volume.
3. Net income in the fourth quarter was $26.5 million, a 76.3% increase year over year.
4. Globus Medical expects 2025 sales to reach $2.8 billion to $2.9 billion.
5. “Despite the complexities of integration, we delivered record fourth quarter and full year sales, while maintaining our disciplined approach to operational excellence and cost management,” Keith Pfeil, COO-CFO said in a news release. “Our team executed against the strategic objectives to drive integration success, which has unlocked tremendous value, as demonstrated in our financial results, which include record operating cash flow for the fourth quarter and full year. Looking ahead, we remain well positioned to unlock operational efficiencies, while delivering innovation and market leadership.”
